While realizing the value to themselves and their employees, the complexities of HSAs and HRAs are starting to sink in to many small to medium size companies.
Continuing a trend towards reducing the direct cost of drugs outside of negotiated insurance rates, Merck & Co. announced a discount-drug program for uninsured Americans.